Noticias de BIIB_US

Noticias del mercado

Últimas noticias sobre BIIB_US — 267 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: BIIB_US ✕ 267 resultados
31/03/2026 BIIB_US — Seeking Alpha
Biogen Inc. (BIIB) Discusses Proposed Acquisition of Apellis and Strategic Growth Objectives - Slideshow
31/03/2026 BIIB_US — Stock Titan
[8-K] BIOGEN INC. Reports Material Event
31/03/2026 BIIB_US — Biogen
Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology
31/03/2026 BIIB_US — BioWorld News
Highly complementary Biogen pays $5.6B; who’s jealous of Apellis?
31/03/2026 BIIB_US — The Business Journals ES ← EN
Biogen comprará Waltham Biotech por 5.600 millones de dólares
31/03/2026 BIIB_US — Zacks Investment Research
Biogen Secures FDA Nod for Higher Dose of SMA Drug Spinraza
30/03/2026 BIIB_US — Investing.com ES ← EN
Morgan Stanley reitera la calificación de igual peso de las acciones de Biogen sobre los datos sobre medicamentos contra el lupus
30/03/2026 BIIB_US — Biogen
FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
30/03/2026 BIIB_US — MarketWatch
Biogen Inc. stock outperforms competitors on strong trading day
30/03/2026 BIIB_US — Via Ritzau
Biogen Inc.
28/03/2026 BIIB_US — Biogen
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
28/03/2026 BIIB_US — Yahoo Finance
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
28/03/2026 BIIB_US — Via Ritzau
Biogen Inc.
27/03/2026 BIIB_US — MSN
Here's why Biogen Inc. (BIIB) is a strong value stock
27/03/2026 BIIB_US — Yahoo Finance
Here's Why Biogen Inc. (BIIB) is a Strong Value Stock
26/03/2026 BIIB_US — Stock Titan
Vanguard disaggregates holdings; reports 0 shares in Biogen (NASDAQ: BIIB)
25/03/2026 BIIB_US — MSN ES ← EN
Leqembi, el medicamento contra el Alzheimer de Biogen Inc. (BIIB), obtiene la aprobación de la UE y ahora está aprobado en 48 países
25/03/2026 BIIB_US — MarketWatch
Biogen Inc. stock outperforms competitors on strong trading day
23/03/2026 BIIB_US — TIKR.com
Biogen Inc. Stock Stifel CNS Forum: $190 Target Price Driven by Tau Pipeline Pivot
20/03/2026 BIIB_US — Biogen
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI® (lecanemab-irmb) in the United States Presented at AD/PD™ 2026

Página 12 de 14

keyboard_arrow_up